Thursday, August 13, 2015

Nascent Biotech Achieves Two Key Milestones in Development of its Novel Brain Cancer Treatment

… /Phase 2 human trials on Brain Cancers, with more than adequate amounts … Orphan Drug Designation for Gliomas (brain cancer).  "This will give us …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)